Latest Market Positioning News

SKS Technologies has been awarded a $100 million contract to fit out electrical infrastructure for a new data centre building in Melbourne, marking a significant boost to its project pipeline and work on hand.

Jupiter Energy has secured extended interest-free terms on its debt and capped repayments as it pursues a dual listing on the Astana International Exchange, aiming to strengthen its financial footing for growth.

The ACCC has decided not to oppose Insurance Australia Group’s proposed acquisition of RACQ Insurance, finding that competition in Queensland’s motor and home contents insurance markets remains robust despite the deal.

Solis Minerals has launched a 2,500-metre diamond drilling campaign at its Chancho al Palo project in Peru, with additional drilling and survey programs advancing across its southern Peru copper-gold portfolio.

Fortescue Metals Group updates on the Iron Bridge magnetite project, projecting a steady ramp-up to full capacity by FY28 with operational improvements driving production and cost efficiencies.

Ventia Services Group Limited delivered strong financial results for 2024, highlighted by a 12.8% rise in NPATA and a record 92% contract renewal rate, while reaffirming growth guidance despite ongoing ACCC proceedings.

Elixinol Wellness Ltd has raised $1.5 million through a mix of debt and equity to boost automation and expand its key brands, including Healthy Chef and Soul Seeds.

Brightstar Resources outlines an ambitious growth plan to boost gold production from 20koz to 200koz per annum by 2029, anchored by upcoming feasibility studies and resource upgrades across its Western Australian hubs.

Bell Financial Group delivered strong financial results for 2024, driven by growth in technology and product services, but early 2025 shows challenges from market volatility impacting core broking revenues.

Infomedia Ltd has responded to an ASX price query following a sharp share price decline and increased trading volume, denying any undisclosed material information. The company pointed to the recent closure of Celeste Funds, a known shareholder, as a potential external factor influencing market activity.

Island Pharmaceuticals has raised $3.6 million through a strategic share placement to advance its lead antiviral drug ISLA-101’s clinical development and broaden its asset portfolio ahead of pivotal Phase 2a/b trial results.

First Au Limited’s trading suspension has been lifted following its announcement of a significant gold asset acquisition, signaling renewed market activity for the miner.